Investment Managers Series Trus (IREX) › Analysis

Investment Managers Series Trus (IREX) analysis, February 2, 2026

Published February 2, 2026 · updated 2026-03-11 · IREX chart, levels and live analysis

Executive Summary

IREX has gained 13.43% since the January 6 report, rising from $16.01 to $18.16, though the security experienced significant intraday volatility with a 20.56% decline over the past 24 hours. The YTD performance of +79.45% reflects continued recovery from the severe Q4 2025 drawdown, though recent price action suggests heightened volatility persists. REX Shares continues aggressive product expansion with three new leveraged ETF launches in January 2026, demonstrating operational momentum despite the absence of specific financial performance data for IREX itself.

Key Updates

Since the January 6 report, IREX has advanced 13.43% to $18.16, though the 1-day decline of -20.56% and 5-day decline of -13.52% indicate substantial recent volatility. The 1-month gain of +79.45% (matching YTD performance) confirms the recovery trajectory from the December lows remains intact, though the security has not yet reclaimed the $36+ levels observed in October 2025. REX Shares demonstrated continued operational expansion through January 2026, launching three distinct ETF products: RDWU (2x Redwire), TLDR (Laddered T-Bill), and EOSU (2x EOSE), expanding its suite to over 30 leveraged single-stock ETFs. The competitive landscape intensified as Tradr ETFs launched multiple competing leveraged products, indicating robust demand for single-stock leveraged instruments.

Current Trend

IREX exhibits a volatile recovery pattern with YTD gains of +79.45% from deeply oversold levels. The security has established a trading range between $10.42 (December 31 low) and $18.16 (current price), representing a 74% recovery from the trough but remaining approximately 50% below the October 2025 peak of $36.23. The recent 20.56% single-day decline suggests resistance near the $23 level (implied from 1-day movement) and highlights the continued elevated volatility characteristic of leveraged ETF issuers. Support appears established at the $10-$11 zone tested in late December 2025, while the $18-$20 range represents near-term resistance. The 5-day decline of -13.52% following the 1-month surge indicates profit-taking after the substantial recovery rally.

Investment Thesis

The investment case for IREX centers on REX Shares' position as a first-mover in the rapidly expanding single-stock leveraged ETF market, capturing demand from sophisticated traders seeking high-conviction directional exposure without margin or options complexity. The company's aggressive product development cycle—launching three distinct products in January 2026 alone—demonstrates operational agility and market responsiveness. REX Shares has expanded its addressable market beyond pure equity leverage to include fixed income products (TLDR), diversifying revenue streams while maintaining its core leveraged equity franchise. The T-REX suite now encompasses over 30 products spanning aerospace (RDWU), energy storage (EOSU), cryptocurrency, and traditional mega-cap technology names, providing multiple growth vectors. However, the thesis faces structural headwinds from intensifying competition (Tradr's $2 billion AUM and 58-fund lineup), regulatory scrutiny of leveraged products, and inherent volatility in fee-generating AUM as these daily-reset instruments experience significant decay in sideways markets.

Thesis Status

The investment thesis remains partially validated but faces execution challenges. REX Shares continues demonstrating product innovation leadership with three January 2026 launches, confirming its ability to identify and capitalize on emerging trading themes (defense/aerospace via RDWU, energy transition via EOSU). The expansion into fixed income with TLDR represents strategic diversification that could provide more stable AUM and fee income compared to volatile leveraged equity products. However, the 50% decline from October 2025 peaks and persistent volatility suggest market concerns about either fee compression from competition, regulatory risk, or sustainability of the leveraged ETF boom. The absence of disclosed AUM figures for IREX or the broader REX Shares platform in recent announcements prevents assessment of whether product launches translate to meaningful asset gathering. Tradr's disclosed $2 billion AUM across 58 funds provides competitive context, suggesting REX Shares may control similar or smaller market share despite its first-mover advantage. The thesis requires validation through disclosed AUM growth and fee revenue metrics to confirm that product proliferation drives sustainable profitability.

Key Drivers

Product expansion velocity remains the primary operational driver, with REX Shares launching RDWU (2x Redwire ETF) on January 31, TLDR (Laddered T-Bill ETF) on January 21, and EOSU (2x EOSE ETF) on January 14, demonstrating sustained innovation. Competitive intensity escalated as Tradr launched four short leveraged ETFs on January 22 and four additional long leveraged products on January 13, directly competing for trader mindshare and AUM. The broader market infrastructure showed robust health, with ICE reporting record 2025 volumes including 40% growth in NYSE equity ADV and 12.6% growth in NYSE Options, confirming strong underlying demand for trading products. Market volatility and elevated trading activity create favorable conditions for leveraged product utilization, though extended sideways price action in underlying stocks could reduce appeal. Regulatory developments and potential scrutiny of leveraged single-stock products represent unquantified but material risks to the business model sustainability.

Technical Analysis

IREX displays classic post-capitulation recovery characteristics with a V-shaped rebound from $10.42 (December 31) to $18.16 (current), representing 74% appreciation. The recent 20.56% single-day decline from approximately $22.85 (implied) suggests strong resistance in the $22-$23 zone, potentially representing the 50% retracement level of the October-December decline from $36.23 to $10.42. The 5-day decline of -13.52% confirms short-term momentum exhaustion after the 79.45% one-month rally, indicating healthy consolidation rather than trend reversal. Volume patterns cannot be assessed from provided data, but the magnitude of daily price swings suggests elevated volatility and active trading interest. Key technical levels include support at $16.00 (January 6 price), $10.42 (December 31 low), and resistance at $18.16 (current), $22-$23 (recent rejection zone), and $36.23 (October 2025 high). The security requires sustained trading above $20 to confirm continuation of the recovery trend, while a break below $16 would signal renewed distribution pressure.

Bull Case

Bear Case

Get a message when the IREX picture changes — the agent team watches the levels and the news for you.Create a free account

More IREX analyses